ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) (ARDIS-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00552565
Recruitment Status : Completed
First Posted : November 2, 2007
Last Update Posted : June 11, 2009
Sponsor:
Information provided by:
AGI Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2009
  Actual Study Completion Date : June 2009